| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $11.80B | -1.7% |
| R&D Expense | $32.0M | -3.0% |
| SG&A Expense | $597.0M | +2.6% |
| Operating Income | $1.42B | +11.8% |
| Interest Expense | $452.0M | +3.7% |
| Pre-tax Income | $743.0M | -6.5% |
| Income Tax | $183.0M | -17.6% |
| Net Income | $424.0M | -5.8% |
| EPS (Basic) | $3.56 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $918.0M | -29.9% |
| Accounts Receivable | $1.03B | -5.8% |
| Inventory | $1.44B | -10.7% |
| Current Assets | $4.21B | -12.9% |
| Total Assets | $13.85B | -7.9% |
| Current Liabilities | $3.46B | -17.5% |
| Long-term Debt | $6.14B | -17.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.19B | -18.0% |
| Capital Expenditures | $403.0M | -49.2% |
| Investing Cash Flow | -$12.0M | +98.5% |
| Financing Cash Flow | -$1.53B | -1415.5% |
| Free Cash Flow | $789.0M | +19.5% |
| -5.6% |
| EPS (Diluted) | $3.55 | -5.6% |
| Stockholders' Equity |
| $2.76B |
| +14.4% |